Syschem India Ltd — Updates, 22-05-2025: Company Update

Syschem India Limited is growing its bulk drug and intermediates manufacturing business, focusing on reducing reliance on imports by expanding capacity and producing key pharmaceutical intermediates, especially amoxicillin and ampicillin. The company’s broad product portfolio serves both domestic and diverse international markets across Latin America, Africa, Asia, and Europe. Recent investments in a new plant aim to boost production and support entry into new international markets by 2025. Syschem’s strategy emphasizes innovation, robust supply chains, and stronger direct customer engagement to drive sustainable growth, improve profitability, and enhance shareholder value.